| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $61.16B | +8.6% |
| Cost of Revenue | $18.20B | +7.7% |
| Gross Profit | $12.07B | — |
| R&D Expense | $9.10B | -28.9% |
| SG&A Expense | $14.01B | -5.0% |
| Operating Income | $15.07B | +65.0% |
| Interest Expense | $2.89B | +3.0% |
| Pre-tax Income | $6.60B | +77.5% |
| Income Tax | $2.36B |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.23B | -5.3% |
| Short-term Investments | $28.0M | -9.7% |
| Accounts Receivable | $12.59B | +15.3% |
| Inventory | $4.95B | +18.4% |
| Current Assets | $29.06B | +13.6% |
| Total Assets | $133.96B | -0.9% |
| Current Liabilities | $43.29B | +11.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $19.03B | +1.2% |
| Capital Expenditures | $1.21B | +24.6% |
| Investing Cash Flow | -$6.64B | +68.1% |
| Financing Cash Flow | -$12.72B | -144.2% |
| Free Cash Flow | $17.82B | -0.1% |
| +514.7% |
| Net Income | $4.23B | -1.2% |
| EPS (Basic) | $2.37 | -1.2% |
| EPS (Diluted) | $2.36 | -1.3% |
| Long-term Debt |
| $64.50B |
| -3.5% |
| Stockholders' Equity | -$3.27B | -198.3% |